Market Place
Sourcing Support
Cue Biopharma Announces Strategic Organizational Transition
14 Nov 2024 //
GLOBENEWSWIRE
Cue Biopharma Reports Q3 2024 Financial Results & Highlights
14 Nov 2024 //
GLOBENEWSWIRE
Cue Biopharma CUE-101, CUE-102 Data in Head & Neck Cancer
08 Nov 2024 //
GLOBENEWSWIRE
Cue Biopharma Announces Presentations At SITC Annual Meeting
04 Oct 2024 //
GLOBENEWSWIRE
Cue Biopharma Announces Proposed Public Offering
26 Sep 2024 //
GLOBENEWSWIRE
Cue Biopharma Announces Pricing of $12.0 Million Public Offering
26 Sep 2024 //
GLOBENEWSWIRE
Cue Biopharma Appoints Lucinda Warren As CBO
09 Sep 2024 //
GLOBENEWSWIRE
Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference
03 Sep 2024 //
GLOBENEWSWIRE
Cue Biopharma Reports Q2 2024 Financial Results And Business Highlights
19 Aug 2024 //
GLOBENEWSWIRE
Cue Biopharma to Host Business Update Call and Webcast
13 Aug 2024 //
GLOBENEWSWIRE
Cue Cuts 25% Jobs, Focuses On Preclinical Over Clinical-Stage Assets
26 Jul 2024 //
FIERCE BIOTECH
Cue Biopharma Prioritizes Autoimmune Programs, Optimizes Workforce
25 Jul 2024 //
GLOBENEWSWIRE
Cue Biopharma: Updated CUE-101 Data In HPV+ Head And Neck Cancer At ASCO
04 Jun 2024 //
GLOBENEWSWIRE
Cue Bio To Present At Two June Healthcare Investor Conferences
03 Jun 2024 //
GLOBENEWSWIRE
Cue Biopharma Q1 2024 Financials And Business Highlights
09 May 2024 //
GLOBENEWSWIRE
Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
08 May 2024 //
GLOBENEWSWIRE
Cue Biopharma To Participate In Fireside Chat At Citizens JMP Conference
07 May 2024 //
GLOBENEWSWIRE
Cue Biopharma to Present at ASCO 2024 Annual Meeting
24 Apr 2024 //
GLOBENEWSWIRE
Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results
08 Apr 2024 //
GLOBENEWSWIRE
Cue Biopharma to Host Business Update Call and Webcast
02 Apr 2024 //
GLOBENEWSWIRE
Cue Biopharma™s Lead Clinical Asset, CUE-101, to be Featured
29 Feb 2024 //
GLOBENEWSWIRE
Cue to Present Corporate Update at the Oppenheimer 34th Annual Conference
06 Feb 2024 //
GLOBENEWSWIRE
Cue Biopharma to Present at the JMP Securities Hematology and Oncology Summit
22 Nov 2023 //
GLOBENEWSWIRE
Cue Bio to Present at Three Upcoming Investor Healthcare Conferences in November
07 Nov 2023 //
GLOBENEWSWIRE
Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101
03 Nov 2023 //
GLOBENEWSWIRE
Cue Biopharma to Host Business Update Call and Webcast
02 Nov 2023 //
GLOBENEWSWIRE
Cue Biopharma Announces Upcoming Scientific Presentations at SITC
27 Sep 2023 //
GLOBENEWSWIRE
Cue Bio Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101
26 Sep 2023 //
GLOBENEWSWIRE
Cue Biopharma Reports Second Quarter 2023 Financial Results
09 Aug 2023 //
GLOBENEWSWIRE
Cue Biopharma to Host Business Update Call and Webcast
02 Aug 2023 //
GLOBENEWSWIRE
Cue Biopharma to Present at the FOCIS 2023 Annual Meeting
14 Jun 2023 //
GLOBENEWSWIRE
Cue Biopharma to Host Investor Call
07 Jun 2023 //
GLOBENEWSWIRE
Cue Biopharma to Present at the Jefferies 2023 Global Healthcare Conference
05 Jun 2023 //
GLOBENEWSWIRE
Cue Bio Presents Positive Data Update from Ongoing Phase 1 Trials of CUE-101
25 May 2023 //
GLOBENEWSWIRE
Cue Biopharma to Present at the 2023(ASCO) Annual Meeting
15 May 2023 //
GLOBENEWSWIRE
Cue Biopharma Reports1Q 2023 FYR and Recent Business Highlights
09 May 2023 //
GLOBENEWSWIRE
Cue Biopharma to Present at the Upcoming JMP Securities Life Sciences Conference
08 May 2023 //
GLOBENEWSWIRE
Cue Biopharma Welcomes Seasoned Pharmaceutical Executive
25 Apr 2023 //
GLOBENEWSWIRE
Cue Biopharma Welcomes Mr. Patrick Verheyen to Board of Directors
12 Apr 2023 //
GLOBENEWSWIRE
Cue Biopharma Reports Fourth Quarter and Full Year 2022 Financial Results
21 Mar 2023 //
GLOBENEWSWIRE
Cue Biopharma to Host Business Update Call and Webcast
15 Mar 2023 //
GLOBENEWSWIRE
Cue Biopharma to Present at Two March 2023 Investor Healthcare Conferences
01 Mar 2023 //
GLOBENEWSWIRE
Cue Biopharma Enters into Collaboration with Ono Pharmaceutical for CUE-401
22 Feb 2023 //
GLOBENEWSWIRE
Cue Biopharma Announces the Appointment of Dr. Rafi Ahmed to Advisory Board
16 Feb 2023 //
GLOBENEWSWIRE
Cue Bio Immuno-STAT Biologics to be Featured in Oxford University Presentation
16 Feb 2023 //
GLOBENEWSWIRE
Cue Biopharma to Present at Two February 2023 Scientific Conferences
01 Feb 2023 //
GLOBENEWSWIRE
Cue Biopharma Announces Chief Medical Officer Transition
23 Jan 2023 //
GLOBENEWSWIRE
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences
22 Nov 2022 //
GLOBENEWSWIRE
Cue Biopharma Announces $30 M Private Investment in Public Equity Financing
14 Nov 2022 //
GLOBENEWSWIRE
Cue Biopharma Reports Third Quarter 2022 Financial Results
14 Nov 2022 //
GLOBENEWSWIRE
Cue Biopharma Presents New Positive Data from Ongoing Phase 1 Trial of CUE-101
10 Nov 2022 //
GLOBENEWSWIRE
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in Nov
09 Nov 2022 //
GLOBENEWSWIRE
Cue Biopharma Announces Upcoming Scientific Presentations at the’s (SITC)
05 Oct 2022 //
GLOBENEWSWIRE
Cue Biopharma Granted FDA Fast Track Designation for CUE-101
04 Oct 2022 //
GLOBENEWSWIRE
Cue Biopharma to Present at Two September 2022 Scientific Conferences
07 Sep 2022 //
GLOBENEWSWIRE
Cue Biopharma begins patient dosing in phase 1 study of CUE-102
24 Aug 2022 //
PHARMABIZ
Cue Biopharma doses first subject in Phase I trial of WT1-expressing cancers
23 Aug 2022 //
CLINICALTRIALSARENA
Cue Biopharma Doses First Patient in Phase 1 Study of CUE-102
22 Aug 2022 //
GLOBENEWSWIRE
Cue Biopharma Reports Second Quarter 2022 Financial Results
04 Aug 2022 //
GLOBENEWSWIRE
Cue Biopharma to Present at the Guggenheim I&I Spotlight Series
11 Jul 2022 //
GLOBENEWSWIRE
